FrancophonIA/ELRC3.0 huggingface dataset:
English: The studi a substance in the blood called glycosylated haemoglobin (HbA1c), which gives well the blood glucose is c
Slovenian: V študijah so merili raven snovi v krvi, imenovane glikozilirani hemoglobin (HbA1c), ki kaže, kako dobro je raven glukoze v krvi uravnana.
English: It explains e for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of able as tablets (pink:
Slovenian: Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil zdravilo Avandia, na podlagi česar je oblikoval mnenje za odobritev dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
English: It has also been studied in metformin, a sulphonylurea, or both metformin and a sulphonylurea.
Slovenian: Proučevano je bilo tudi pri bolnikih, ki so že jemali metformin, sulfonilsečnino ali oboje.
English: Avandia is used in adults who have type 2 diabetes, particularly those wh addition to diet and exercise.
Slovenian: Zdravilo Avandia se uporablja pri odraslih, ki imajo sladkorno bolezen tipa 2, še zlasti pri bolnikih s čezmerno telesno maso.
English: Type 2 diabetes is a disease in which the pancreas does not make enough insulin t glucose in the blood or when the
Slovenian: Sladkorna bolezen tipa 2 je bolezen, pri kateri trebušna slinavka ne tvori dovolj insulina za vzdrževanje primerne ravni glukoze v krvi ali pri kateri telo ne more učinkovito izrabljati insulina.
English: Avandia can also be used in combination with metformin in patients who are not satisfactorily controlled on metformin alone, or with a sulphonylurea (another type of antidiabetes medicine) when metformin is not suitable (‘dual therapy').
Slovenian: Zdravilo Avandia se lahko uporablja tudi v kombinaciji z metforminom pri bolnikih s sladkorno boleznijo tipa 2, pri katerih zgolj z metforminom ni mogoče doseči zadovoljivega nadzora, ali v kombinaciji s sulfonilsečnino (drugo vrsto zdravila proti sladkorni bolezni), če metformin ni primeren (zdravljenje z dvema zdraviloma).
English: This dose may need to be increased to 8 mg per day after eight weeks if better bl sulphonylurea, due to the r
Slovenian: Če je potrebno močnejše uravnavanje koncentracije glukoze (sladkorja) v krvi, se lahko ta odmerek po osmih tednih poveča na 8 mg na dan, vendar pa je pri bolnikih, ki hkrati jemljejo tudi sulfonilsečnino, potrebna previdnost zaradi tveganja za zastajanje tekočine.
English: What is Avandia used for?
Slovenian: Za kaj se zdravilo Avandia uporablja?
English: If Avandia is used in combination with other antidiabetes medicines, other this can lead to heart und the body).
Slovenian: Če se zdravilo Avandia uporablja v kombinaciji z drugimi zdravili proti sladkorni bolezni, se lahko pojavijo še drugi neželeni učinki.
English: How has Avandia been studied?
Slovenian: Kako je bilo zdravilo Avandia raziskano?
English: How does Avandia work?
Slovenian: Kako zdravilo Avandia deluje?
English: Avandia can also be used with both metformin and a sulphonylurea in patients who are not satisfactorily controlled despite dual therapy by mouth (‘triple therapy').
Slovenian: Zdravilo Avandia se lahko uporablja tudi z metforminom in sulfonilsečnino (zdravljenje s tremi zdravili) hkrati pri bolnikih, pri katerih nadzor kljub dvojnemu peroralnemu zdravljenju ni zadosten.
English: How is Avandia used?
Slovenian: Kako se zdravilo Avandia uporablja?
English: The full EPAR for Avandia can be found here
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Avandia je na voljo tukaj.
English: Com antidiabetes medicines led to further decreases in the level of HbA1c, ind levels had been further reduced.
Slovenian: Kombiniranje z drugimi zdravili proti sladkorni bolezni je še nadalje znižalo koncentracijo HbA1c, kar kaže, da se je koncentracija glukoze v krvi dodatno zmanjšala.
English: Avandia, rosiglitazone, makes cells and this helps to control type 2 diabetes.
Slovenian: Posledično se količina glukoze v krvi zmanjša, kar pripomore k nadzoru sladkorne bolezni tipa 2.
English: What is Avandia?
Slovenian: Kaj je zdravilo Avandia?
English: It is used in hom metformin (another antidiabetes medicine) is not suitable.
Slovenian: Zdravilo Avandia se uporablja samostojno pri bolnikih, za katere metformin (drugo zdravilo proti sladkorni bolezni) ni primerno.
English: Avandia, used on its own, has been compared with placebo (a dummy treatment), metformin and patients who were already using es measured the level of an indication of how ontrolled.
Slovenian: Zdravilo Avandia, uporabljeno samostojno, so primerjali s placebom (zdravilom brez zdravilne učinkovine), metforminom in glibenklamidom (sulfonilsečnino).
English: What benefit has Avandia shown
Slovenian: Kakšne koristi je zdravilo Avandia izkazalo med študijami?
English: Ref.: EMEA/717671/2009 EMEA/H/C/1093
Slovenian: : EMEA/711398/2009 EMEA/H/C/1093
English: It is available as white tablets (75, 150 and 300 mg).
Slovenian: Na voljo je v obliki belih tablet (75, 150 in 300 mg).
English: Irbesartan Teva is not recommended for use in patients below 18 years of age, because of a lack of information on safety and effectiveness in this age group.
Slovenian: Zdravilo Irbesartan Teva ni priporočeno za uporabo pri bolnikih, mlajših od 18 let, zaradi pomanjkanja podatkov o varnosti in učinkovitosti v tej starostni skupini.
English: The usual recommended dose is 150 mg once a day.
Slovenian: Običajni priporočeni odmerek znaša 150 mg enkrat dnevno.
English: If the blood pressure is not sufficiently controlled, the dose can be increased to 300 mg a day or other medicines for hypertension can be added, such as hydrochlorothiazide.
Slovenian: Če krvni tlak ni zadostno nadzorovan, se odmerek lahko poveča na 300 mg dnevno ali se doda drugo zdravilo za zdravljenje povišanega krvnega tlaka, kot je denimo hidroklorotiazid.
English: Irbesartan Teva is a ‘generic medicine'.
Slovenian: Irbesartan Teva je „generično zdravilo“.
English: This allows the blood pressure to drop, reducing the risks associated with high blood pressure, such as having a stroke.
Slovenian: Zaradi tega se krvni tlak zniža, kar posledično zmanjša tveganja, povezana s previsokim krvnim tlakom, kot je denimo kap.
English: Other information about Irbesartan Teva:
Slovenian: Druge informacije o zdravilu Irbesartan Teva:
English: Irbesartan Teva is used in patients who have essential hypertension (high blood pressure).
Slovenian: Zdravilo Irbesartan Teva se uporablja pri bolnikih, ki imajo esencialno hipertenzijo (visok krvni tlak).
English: What are the benefit and risk of Irbesartan Teva?
Slovenian: Kakšne so koristi in tveganja, povezana z zdravilom Irbesartan Teva?
English: This means that Irbesartan Teva is similar to a ‘reference medicine' already authorised in the European Union (EU) called Aprovel.
Slovenian: To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Aprovel.
English: The Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Irbesartan Teva has been shown to have comparable quality and to be bioequivalent to Aprovel.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da je bilo v s skladu z zahtevami EU dokazano, da ima zdravilo Irbesartan Teva primerljivo raven kakovosti kot zdravilo Aprovel ter mu je biološko enakovredno.
English: The active substance in Irbesartan Teva, irbesartan, is an ‘angiotensin II receptor antagonist', which means that it blocks the action of a hormone in the body called angiotensin II.
Slovenian: Zdravilna učinkovina v zdravilu Irbesartan Teva, irbesartan, je „antagonist receptorjev angiotenzina II“, kar pomeni, da v telesu preprečuje delovanje hormona, imenovanega angiotenzin II.
English: Because Irbesartan Teva is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine.
Slovenian: Ker je zdravilo Irbesartan Teva generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
English: Irbesartan Teva is a medicine that contains the active substance irbesartan.
Slovenian: Irbesartan Teva je zdravilo, ki vsebuje zdravilno učinkovino irbesartan.
English: Therefore, the CHMP's view was that, as for Aprovel, the benefit outweighs the identified risk.
Slovenian: Zaradi tega je CHMP menil, da koristi, tako kot pri zdravilu Aprovel, odtehtajo znana tveganja.
English: Irbesartan Teva is taken by mouth, with or without food.
Slovenian: Zdravilo Irbesartan Teva se zaužije peroralno, s hrano ali brez nje.
English: A starting dose of 75 mg can be used in patients receiving haemodialysis (a blood clearance technique) or in patients over 75 years of age.
Slovenian: Pri bolnikih na hemodializi (postopku čiščenja krvi) ali pri bolnikih, starejših od 75 let, se lahko uporabi začetni odmerek 75 mg.
English: The Committee recommended that Irbesartan Teva be given marketing authorisation.
Slovenian: Odbor je priporočil, da se za zdravilo Irbesartan Teva odobri dovoljenje za promet.
English: By blocking the receptors to which angiotensin II normally attaches, irbesartan stops the hormone having an effect, allowing the blood vessels to widen.
Slovenian: Irbesartan z blokiranjem receptorjev, na katere se angiotenzin II običajno veže, zavira delovanje tega hormona, kar povzroči razširitev krvnih žil.
English: Because Irbesartan Teva is a generic medicine, studies have been limited to tests to determine that it is bioequivalent to the reference medicine, Aprovel.
Slovenian: Ker je zdravilo Irbesartan Teva generično zdravilo, so bile študije omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Aprovel.
English: In patients with hypertension and type 2 diabetes, Irbesartan Teva is added to other treatments for hypertension.
Slovenian: Pri bolnikih z visokim krvnim tlakom in sladkorno boleznijo tipa 2 se zdravilo Irbesartan Teva uvede poleg drugih načinov zdravljenja hipertenzije.
English: Irbesartan Teva is also used to treat kidney disease in patients with hypertension and type 2 diabetes (non-insulin-dependent diabetes).
Slovenian: Zdravilo Irbesartan Teva se uporablja tudi za zdravljenje ledvičnega obolenja pri bolnikih s hipertenzijo in sladkorno boleznijo tipa 2 (ki je neodvisna od insulina).
English: Why has Irbesartan Teva been approved?
Slovenian: Zakaj je bilo zdravilo Irbesartan Teva odobreno?
English: The European Commission granted a marketing authorisation valid throughout the European Union for Irbesartan Teva to Teva Pharma B.V. on 30 October 2009.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Irbesartan Teva, veljavno po vsej Evropski uniji, odobrila družbi Teva Pharma B.V.
English: The full EPAR for Irbesartan Teva can be found here.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Irbesartan Teva je na voljo tukaj.
English: How has Irbesartan Teva been studied?
Slovenian: Kako je bilo zdravilo Irbesartan Teva raziskano?
English: How is Irbesartan Teva used?
Slovenian: Kako se zdravilo Irbesartan Teva uporablja?
English: What is Irbesartan Teva used for?
Slovenian: Za kaj se zdravilo Irbesartan Teva uporablja?
English: How does Irbesartan Teva work?
Slovenian: Kako zdravilo Irbesartan Teva deluje?
English: What is Irbesartan Teva?
Slovenian: Kaj je zdravilo Irbesartan Teva?
English: It can be taken at any time of day.
Slovenian: Vzame se lahko kadar koli podnevi.
English: This summary was last updated in 06-2012.
Slovenian: Povzetek je bil nazadnje posodobljen 06-2012.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Fablyn on 24 February 2009.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Fablyn , veljavno po vsej Evropski uniji, odobrila dne 24. februarja 2009.
English: It must not be used in women with unexplained bleeding from the womb.
Slovenian: Ne sme se uporabljati pri ženskah z nepojasnjeno krvavitvijo iz maternice.
English: The recommended dose of Fablyn is one tablet once a day.
Slovenian: Priporočeni odmerek zdravila Fablyn je ena tableta enkrat dnevno.
English: Fablyn lasofoxifene
Slovenian: Fablyn lasofoksifen
English: Also, results with the 250-microgram dose were pointing to 500 micrograms being more effective.
Slovenian: Izidi z 250-mikrogramskim odmerkom so prav tako pokazali, da je 500-mikrogramski odmerek učinkovitejši.
English: The full EPAR for Fablyn can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Fablyn je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: This is a summary of the European public assessment report (EPAR) for Fablyn.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Fablyn.
English: Over five years, 6% of the women taking Fablyn 500 micrograms had a new spine fracture (155 out of 2,748), compared with 9% of those taking placebo (255 out of 2,744).
Slovenian: V petih letih se je nov zlom hrbtenice pojavil pri 6 % žensk, ki so jemale zdravilo Fablyn 500 mikrogramov (155 od 2 748), medtem ko je do novega zloma prišlo pri 9 % tistih, ki so jemale placebo (255 od 2 744).
English: The effects of Fablyn were first tested in experimental models before being studied in humans.
Slovenian: Učinki zdravila Fablyn so bili najprej preskušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
English: The main measure of effectiveness was the number of women who had a new fracture in the spine as seen on X-rays.
Slovenian: Glavno merilo učinkovitosti je bilo število žensk z novim zlomom hrbtenice, kar je bilo ugotovljeno z rentgenskim slikanjem.
English: What measures are being taken to ensure the safe use of Fablyn?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne uporabe zdravila Fablyn?
English: The programme will include information about the risk of venous thromboembolism, changes in the womb that may occur when taking the medicine, and the need to investigate unexplained bleeding from the womb.
Slovenian: Program bo vključeval podatke o tveganju za nastanek venske trombembolije, spremembah v maternici, ki se lahko pojavijo pri jemanju zdravila in potrebi po preiskavi nepojasnjenega krvavenja iz maternice.
English: The study also looked at existing spine fractures that got worse, new fractures in other parts of the body and the density of bones throughout the body.
Slovenian: V študiji so proučevali tudi obstoječe zlome hrbtenice, katerih stanje se je poslabšalo, nove zlome v drugih delih telesa in gostoto kosti v celem telesu.
English: The company that makes Fablyn will make sure that an educational programme is available in all Member States for all healthcare workers who will prescribe Fablyn or order pelvic ultrasound scans for women taking the medicine.
Slovenian: Družba, ki izdeluje zdravilo Fablyn, bo zagotovila, da bo izobraževalni program na voljo v vseh državah članicah za vse zdravstvene delavce, ki bodo predpisovali zdravilo Fablyn ali napotili ženske, ki jemljejo zdravilo, na ultrazvočno slikanje medenice.
English: For more information about treatment with Fablyn, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Fablyn preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: The CHMP decided that Fablyn's benefits are greater than its risks and recommended that it be given marketing authorisation.
Slovenian: CHMP je zaključil, da so koristi zdravila Fablyn večje od z njim povezanih tveganj, in priporočil, da se zanj odobri dovoljenje za promet.
English: Fablyn was more effective than placebo at reducing the number of new fractures.
Slovenian: Zdravilo Fablyn je bilo pri zmanjšanju števila novih zlomov učinkovitejše od placeba.
English: Fablyn is only for use in women who have been through the menopause, so it must not be used in women who could become pregnant, or women who are pregnant or breastfeeding.
Slovenian: Zdravilo Fablyn je namenjeno le ženskam po menopavzi, zato ga ne smejo uporabljati ženske, ki bi lahko zanosile, nosečnice ali ženske, ki dojijo.
English: Other information about Fablyn
Slovenian: Druge informacije o zdravilu Fablyn
English: It must not be used in patients who have had problems with venous thromboembolism including deep vein thrombosis (DVT), pulmonary embolism (a blood clot in the lungs) and retinal vein thrombosis (a blood clot at the back of the eye).
Slovenian: Ne sme se uporabljati pri bolnicah, ki so imele težave zaradi venske trombembolije, vključno z globoko vensko trombozo (DTV), pljučno embolijo (krvnim strdkom v pljučih) in trombozo ven mrežnice (krvnim strdkom v zadnjem delu očesa).
English: What benefit has Fablyn shown during the studies?
Slovenian: Kakšne koristi je zdravilo Fablyn izkazalo med študijami?
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Fablyn.
Slovenian: Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil zdravilo Fablyn, na podlagi česar je oblikoval mnenje za odobritev dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
English: Fablyn must not be used in people who are hypersensitive (allergic) to lasofoxifene or any of the other ingredients.
Slovenian: Zdravila Fablyn ne smejo uporabljati osebe, ki so preobčutljive za (alergične na) lasofoksifen ali katere koli druge sestavine zdravila.
English: The most common side effect with Fablyn (seen in more than 1 patient in 10) is muscle cramps.
Slovenian: Najpogostejši neželeni učinek zdravila Fablyn (opažen pri več kot 1 od 10 bolnic) so mišični krči.
English: It is used in women who are at risk of fracture (broken bones).
Slovenian: Uporablja se pri ženskah, pri katerih obstaja tveganje za zlom kosti.
English: When deciding whether to prescribe Fablyn or other treatments, doctors should consider whether the patient has any symptoms of the menopause, and the possible effects of treatment on the womb, the breast, and the heart and blood vessels.
Slovenian: Zdravnik mora, preden predpiše zdravilo Fablyn ali druga zdravljenja, ugotoviti prisotnost kakršnih koli znakov menopavze pri bolnici ter presoditi morebitne učinke zdravljenja na maternico, prsi, srce in krvne žile.
English: The active substance in Fablyn, lasofoxifene, is a selective oestrogen receptor modulator (SERM).
Slovenian: Zdravilna učinkovina zdravila Fablyn, lasofoksifen, je selektivni modulator estrogenskih receptorjev (SERM).
English: Patients may also receive calcium and vitamin D supplements if they do not get enough from their diet. Fablyn is intended for long-term use.
Slovenian: Bolnice lahko po potrebi jemljejo tudi dodatek kalcija in vitamina D, če ju ne dobijo dovolj s prehrano.
English: What is the risk associated with Fablyn?
Slovenian: Kakšna tveganja so povezana z zdravilom Fablyn?
English: Lasofoxifene acts as an ‘agonist' of the oestrogen receptor (a substance that stimulates the receptor for oestrogen) in some tissues in the body.
Slovenian: Lasofoksifen deluje kot agonist receptorjev estrogena (snov, ki stimulira receptorje za estrogen) v nekaterih telesnih tkivih.
English: Fablyn is a medicine that contains the active substance lasofoxifene.
Slovenian: Fablyn je zdravilo, ki vsebuje zdravilno učinkovino lasofoksifen.
English: Lasofoxifene has the same effect as oestrogen in the bone.
Slovenian: Lasofoksifen učinkuje na kost enako kot estrogen.
English: For the full list of all side effects reported with Fablyn, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Fablyn, glejte navodilo za uporabo.
English: Fablyn is used for the treatment of osteoporosis (a disease that makes bones fragile) in postmenopausal women (women who have been through the menopause).
Slovenian: Zdravilo Fablyn se uporablja za zdravljenje osteoporoze (bolezni, ki povzroča krhkost kosti) pri ženskah po menopavzi.
English: Fablyn did not reduce the number of hip fractures to a level that would be relevant for patients.
Slovenian: Zdravilo Fablyn ni zmanjšalo števila zlomov kolka v tolikšni meri, da bi bilo to za bolnice pomembno.
English: Why has Fablyn been approved?
Slovenian: Zakaj je bilo zdravilo Fablyn odobreno?
English: Fablyn has been shown to reduce fractures in the spine and elsewhere in the body, but not in the hip.
Slovenian: Zdravilo Fablyn se je izkazalo kot učinkovito pri zmanjšanju števila zlomov hrbtenice in drugih kosti v telesu, vendar ne zlomov kolka.
English: Fewer women taking the higher dose had a fracture outside the spine and there were greater increases in bone density.
Slovenian: Pri ženskah, ki so jemale večje odmerke, so bili zlomi drugih kosti v telesu redkejši, bolj pa se je povečala tudi kostna gostota.
English: Two doses of Fablyn (250 and 500 micrograms once a day) have been compared with placebo (a dummy treatment) in one main study involving almost 9,000 postmenopausal women with osteoporosis aged 60 to 80 years.
Slovenian: V eni glavni študiji, v katero je bilo vključenih skoraj 9 000 žensk v obdobju po menopavzi, starih od 60 do 80 let, so primerjali dva odmerka zdravila Fablyn (250 in 500 mikrogramov enkrat dnevno) s placebom (zdravilom brez zdravilne učinkovine).
English: Osteoporosis is more common in women after the menopause, when the levels of the female hormone oestrogen fall: oestrogen slows down bone breakdown and makes the bones less likely to fracture.
Slovenian: Osteoporoza je pogostejša pri ženskah v obdobju po menopavzi, ko upade količina ženskega hormona estrogena.
English: What is Fablyn used for?
Slovenian: Za kaj se zdravilo Fablyn uporablja?
English: How has Fablyn been studied?
Slovenian: Kako je bilo zdravilo Fablyn raziskano?
English: How does Fablyn work?
Slovenian: Kako zdravilo Fablyn deluje?
English: What is Fablyn?
Slovenian: Kaj je zdravilo Fablyn?
English: How is Fablyn used?
Slovenian: Kako se zdravilo Fablyn uporablja?
English: Fablyn should be used with caution in women with severe liver or kidney problems.
Slovenian: Pri bolnicah z resnimi obolenji jeter ali ledvic je treba zdravilo Fablyn uporabljati previdno.
English: Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, route of administration, marketing authorisation holders in the Member States
Slovenian: Priloga I Seznam imen, farmacevtskih oblik, jakosti zdravila, poti uporabe zdravila, imetnikov dovoljenja za promet z zdravilom v državah članicah
English: GlaxoSmithKline Slovakia s.r.o., Galvaniho7/A, 82104 Bratislava Slovak Republic
Slovenian: GlaxoSmithKline Slovakia s.r.o., Galvaniho7/A, 82104 Bratislava
English: GlaxoSmithKline GmbH & Co. KG, Theresienhöhe 11 80339 München GERMANY
Slovenian: KG, Theresienhöhe 11 80339 München GERMANY
English: Nykaer 68, 2605
Slovenian: Nykaer 68, 2605 Broendby DENMARK
English: Zinnat 250 mgGranulat
Slovenian: Zinnat 250 mgGranulat zrnca
English: 980 Great West Road Brentford, Middlesex, TW8 9GS
Slovenian: GlaxoSmithKline Export Ltd 980 Great West Road Brentford, Middlesex, TW8 9GS
English: Glaxo Group Ltd., Greenford road, Greenford, Middlesex, UB6 0NN,
Slovenian: Glaxo Group Ltd., Greenford road, Greenford, Middlesex, UB6 0NN, UNITED KINGDOM
English: Zinnat 250 mg apvalkotās tabletes 250mg Film-coated Tablets
Slovenian: Zinnat 250 mg apvalkotās tabletes 250 mg
English: Zinnat 500 mg apvalkotās tabletes 500mg Film-coated Tablets
Slovenian: Zinnat 500 mg apvalkotās tabletes 500 mg
English: Oraxim250 mg Granules for Oral Suspension
Slovenian: Oraxim250 mg zrnca za peroralno suspenzijo
English: Glaxo Wellcome House Berkeley avenue Greenford, Middlesex United Kingdom UB6 0NN
Slovenian: Glaxo Wellcome UK Limited Glaxo Wellcome House Berkeley avenue Greenford, Middlesex United Kingdom UB6 0NN